Befejeződött1. fázis
A clinical study to investigate the safety, tolerability and pharmacokinetic profile of single ascending concentrations of OPT101 in peritoneal dialysis patients.
Key facts
- Where
- Riga, LettországSee the site
- Phase
- 1. fázis
Where in Lettország
- Pauls Stradins Clinical University HospitalRiga, LettországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- OPTERION Health AG
- Trial code
- EU 2025-522966-61-00
- Record updated
- 2026. január 9.